Graduate Coursework Programmes Webinar

Transforming Healthcare Economics for Asia and Beyond with MScHEOR

Date:

8 October 2026, Thursday

Time:

7:30 – 9:00pm Singapore time (GMT+08:00)  

Platform:

Via Zoom

Synopsis:

Across Asia, ageing populations, rising healthcare costs, and rapid medical innovation are increasing the need for health technology assessment (HTA) and market access expertise. Join our webinar to discover how the NUS MSc in Health Economics and Outcomes Research can equip you to evaluate healthcare value, inform pricing and reimbursement, and improve patient access across diverse Asian healthcare systems.

Why choose MScHEOR?

  • Specialised masters tailored to Asian contexts
  • Offered by NUS, ranked #1 in Asia and #8 globally
  • Career-driven curriculum with real-world impact
  • Learn from world-class faculty and industry experts

Career Prospects

  • Public Sector
    Health Technology Assessment agencies (e.g. ACE in Singapore), Ministries of Health, healthcare clusters (e.g. NUHS, NHG, Singhealth), statutory bodies (e.g. Health Promotion Board).
  • Private Sector
    HEOR consultancies, pharmaceutical & MedTech companies, healthcare payers & insurers.
  • Academia
    Universities, government research institutes, non-governmental think tanks.

Speaker:

Associate Professor Alec Morton
Programme Director of MSc in Health Economics & Outcomes Research (MScHEOR)

With over twenty years’ experience in decision modelling, HEOR and Health Technology Assessment, Associate Professor Alec Morton bridges academic research, policy and practice across Asia, Europe and global public-health institutions. He has collaborated with the WHO, Gavi and HTA agencies and ministries of health in Thailand, China and the UK. At NUS he leads the Population Health & Health Economics Modelling (PHRISM) group and has editorial roles at Health Care Management Science, Decision Analysis and the Journal of Multi-Criteria Decision Analysis. His work has ranged across multiple areas of public health and health economics, including antimicrobial resistance, public mental health, and chronic disease surveillance and prevention

Scroll to Top